China Universal Asset Management Company’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
NFT
BPC
PFSRSONJ
S
AWM
AB
FIA
China Universal Asset Management Company's PCVX Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Vaxcyte (PCVX) stake by 10% in Q2 2026, selling an estimated $139K and leaving 22,981 shares worth $1.34M. The position accounts for 0.08% of the portfolio, ranked #180.
China Universal Asset Management Company first reported a position in PCVX in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.65M in Q4 2023. 37 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.
- China Universal Asset Management Company held 22,981 shares of Vaxcyte worth $1.34M as of Q2 2026.
- China Universal Asset Management Company sold 2,559 Vaxcyte shares in Q2 2026, an estimated $139K.
- Vaxcyte made up 0.08% of China Universal Asset Management Company's portfolio in Q2 2026, its #180 holding.
- China Universal Asset Management Company first reported a position in Vaxcyte in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Vaxcyte position peaked at $2.65M in Q4 2023.
- 37 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.